Allergan (NYSE: AGN) posted a solid 4Q leading Piper Jaffray analyst, David Amsellem, to reiterate his Overweight rating but trim ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE